Episode 5. Global & the European Facilitated Regulatory Pathways
Time-to-market plays a major role in addressing the needs of vulnerable patient groups. Facilitated pathways across the globe accelerate the timelines of innovative drug molecules, allowing fast-tracked approval pathways for essential medicines. Our experts address the necessary requirements of innovators and elaborate on the facilitated Regulatory pathways. Reference Links Centre for Innovation in Regulatory Science report New drug approvals in six major authorities 2011-2020